Lexalytics announces new partnerships to improve insights, efficiencies, and patient outcomes
Lexalytics, a provider of machine learning and AI solutions, is partnering with True North Solutions and Glasshouse Health to help medical affairs teams better apply the latest in AI and natural language processing (NLP) technologies and approaches to improve insights, efficiencies, and patient outcomes. True North and Glasshouse bring decades of domain expertise in the pharmaceutical and healthcare industries in the North American and European markets, respectively, and will work with Lexalytics to help their customers understand how applied AI and machine learning (ML) solve real-world business problems.
According to Lexalytics, off-the-shelf technology solutions tend to be poorly suited to address the unique needs of medical affairs in areas such as insight generation, automation, compliance review, educational gap assessment, congress and publication planning, and digital innovation. Lexalytics, True North and Glasshouse have partnered to help med affairs functions better understand how to apply AI and NLP to address all of the noted issues, as well as the many other responsibilities of a Medical Affairs department.
“Over the past few years, we’ve been applying machine learning to many of the facets of pharmaceutical Medical Affairs and commercial functions to improve efficiencies, insights and patient outcomes, and our customers have seen tremendous success through those efforts,” said Jeff Catlin, CEO of Lexalytics. “By partnering with the skilled teams at True North and Glasshouse, we hope to reach more Medical Affairs departments across North America and Europe to quicken adoption and improve outcomes of AI and NLP projects in the space.”
Lexalytics has built AI and NLP solutions for some of the world’s most prominent pharmaceutical and biotech companies, including Avenir, AlternativesPharma, Biogen, Genentech, Sage Therapeutics and more. Some of the recent and ongoing projects that Lexalytics has undertaken in medical affairs with its partners include medical information question-answering system, content aggregation, and field insights and engagement tracking.
“We’ve just begun to scratch the surface of what is possible using AI in Medical Affairs to improve operations and outcomes, and pharmaceutical companies and other healthcare providers are eager to learn about the possibilities,” said Colin Baughman, founder and managing partner, True North Solutions.
“I’ve spent more than two decades driving strategy, product planning, development, patient program development and more with Medical Affairs teams, and I know the critical role technology plays in ensuring success,” added Paul Riley, medical affairs director, Glasshouse Health.
For more information about Lexalytics and its AI for medical affairs program, and to contact the company or its partners, visit www.lexalytics.com/medical-affairs.